2022
DOI: 10.1016/j.neubiorev.2022.104607
|View full text |Cite
|
Sign up to set email alerts
|

Analgesic drug use in pregnancy and neurodevelopment outcomes: an umbrella review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…In vivo animal studies suggest a causal relationship between prenatal APAP exposure and altered behaviors in the offspring, such as stereotyped behavior and hyperactivity [142,143]. These effects have been attributed to APAP's reduction of BDNF levels in the striatum of rats [144,145], as well as alterations in dopamine metabolism [142,143]. Moreover, APAP may also cause oxidative stress and mitochondrial dysfunction, which can contribute to behavioral abnormalities [135].…”
Section: Apap and Asdmentioning
confidence: 99%
“…In vivo animal studies suggest a causal relationship between prenatal APAP exposure and altered behaviors in the offspring, such as stereotyped behavior and hyperactivity [142,143]. These effects have been attributed to APAP's reduction of BDNF levels in the striatum of rats [144,145], as well as alterations in dopamine metabolism [142,143]. Moreover, APAP may also cause oxidative stress and mitochondrial dysfunction, which can contribute to behavioral abnormalities [135].…”
Section: Apap and Asdmentioning
confidence: 99%
“…Drugs that belongs to the above category are aspirin, ibuprofen, naproxen and acetaminophen. 52 NSAIDs are cyclooxygenase enzyme inhibitors that are widely used by 19% of the population for their analgesic, antipyretic, and anti-inflammatory properties. NSAIDS are often used in the first trimester and are generally avoided in the third trimester owing to adverse effects.…”
Section: Analgesic Use In Pregnancymentioning
confidence: 99%
“…Although nearly 9 in 10 pregnant individuals use medication (Lupattelli et al, 2014), only 5% of medications have been adequately monitored, tested, and labelled with safety information for use during pregnancy and lactation (Byrne et al, 2020). Most existing evidence is, moreover, focused on immediate birth outcomes following exposure to medication during pregnancy, whereas there are clear indications that some medications may also affect long-term health outcomes in offspring (Kwok et al, 2022;Dreier et al, 2023). This lack of knowledge hampers evidence-based benefit-risk assessment of prescribing and using medications in clinical practice.…”
Section: Introductionmentioning
confidence: 99%